Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasisSun Lee, Won‐Yoon Chung, Kwang-Kyun Park et al.|Scientific Reports|2017Cited by 71
CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasionJunhee Park, Won‐Yoon Chung, Xianglan Zhang et al.|Journal of Clinical Investigation|2019Cited by 60
Liensinine and Nuciferine, Bioactive Components of <i>Nelumbo nucifera</i>, Inhibit the Growth of Breast Cancer Cells and Breast Cancer‐Associated Bone LossEun Ji Kang, Won‐Yoon Chung, Sun Lee et al.|Evidence-based Complementary and Alternative Medicine|2017Cited by 55
Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatmentSe Young Park, Won‐Yoon Chung, Hyun‐Jeong Kim et al.|Toxicology and Applied Pharmacology|2014Cited by 46
Loss of <scp>RUNX3</scp> expression promotes cancer‐associated bone destruction by regulating <scp>CCL5</scp>, <scp>CCL19</scp> and <scp>CXCL11</scp> in non‐small cell lung cancerHyun‐Jeong Kim, Won‐Yoon Chung, Junhee Park et al.|The Journal of Pathology|2015Cited by 45